Jennifer Clarke
Professor · University of California (San Francisco) School of Medicine
Credentials: · · · · ·
History
Research
Nature Medicine · 2019 · 1,142 citations
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
New England Journal of Medicine · 2023 · 643 citations
JAMA Oncology · 2020 · 506 citations
63 papers
51 papers
45 papers
43 papers · 11 as a resident
28 papers
27 papers
27 papers
21 papers
Grants
- 1999–2028
National Cancer Institute · P30
Project lead · $2.1M · University of California, San Francisco
Clinical trials
- 2018–2024
Feasibility of Individualized Therapy for Recurrent Glioblastoma
Principal investigator · Completed · Phase 1
Jennifer Clarke
- 2014–2021
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Principal investigator · Terminated · Phase 2
University of California, San Francisco
- 2009–2014
HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM
Principal investigator · Completed · Phase 2
University of California, San Francisco
- 2024–2027
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
Study chair · Recruiting · Phase 1
Hideho Okada, MD, PhD